PAV-220830FLY-674

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-674

4419-190603

NHP-220830FLY-6

anti-cd4 infusion premed., pre-dosing vitals; HR 130, RR 30, T 101.0. Interim vitals; HR 140, RR 32, T 99.5. End of infusion vitals; HR 140, RR 30, T 99.1. No adverse reactions. , anti-cd4 infusion premed

https://fairdomhub.org/sops/795

Treatment

Not specified

Flynn Lab

2019-06-03 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

305

milligram

Diphenhydramine

Medication

Intramuscularly

6

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 13

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:36

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH